Xi’an Xintong Medicine Research Co. Ltd. has described Toll-like receptor 8 (TLR8) agonists reported to be useful for the treatment of cancer.

Here's your look at the sci-fi world of G-Rebels in this announcement trailer for the upcoming futuristic aerial combat sim game from developer Reakktor Studios. G-Rebels will be available in 2025.